178 related articles for article (PubMed ID: 20376482)
1. Role of E-cadherin gene in gall bladder cancer and its precursor lesions.
Priya TP; Kapoor VK; Krishnani N; Agrawal V; Agrawal S
Virchows Arch; 2010 May; 456(5):507-14. PubMed ID: 20376482
[TBL] [Abstract][Full Text] [Related]
2. Fragile histidine triad (FHIT) gene and its association with p53 protein expression in the progression of gall bladder cancer.
Priya TP; Kapoor VK; Krishnani N; Agrawal V; Agarwal S
Cancer Invest; 2009 Aug; 27(7):764-73. PubMed ID: 19452299
[TBL] [Abstract][Full Text] [Related]
3. p53, carcinoembryonic antigen and carbohydrate antigen 19.9 expression in gall bladder cancer, precursor epithelial lesions and xanthogranulomatous cholecystitis.
Agrawal V; Goel A; Krishnani N; Pandey R; Agrawal S; Kapoor VK
J Postgrad Med; 2010; 56(4):262-6. PubMed ID: 20935395
[TBL] [Abstract][Full Text] [Related]
4. Anticipatory extended cholecystectomy: the 'Lucknow' approach for thick walled gall bladder with low suspicion of cancer.
Kapoor VK; Singh R; Behari A; Sharma S; Kumar A; Prakash A; Singh RK; Kumar A; Saxena R
Chin Clin Oncol; 2016 Feb; 5(1):8. PubMed ID: 26932432
[TBL] [Abstract][Full Text] [Related]
5. Xanthogranulomatous cholecystitis: a clinicopathological study of its association with gallbladder carcinoma.
Zhuang PY; Zhu MJ; Wang JD; Zhou XP; Quan ZW; Shen J
J Dig Dis; 2013 Jan; 14(1):45-50. PubMed ID: 23134201
[TBL] [Abstract][Full Text] [Related]
6. Xanthogranulomatous cholecystitis: a premalignant condition?
Ghosh M; Sakhuja P; Agarwal AK
Hepatobiliary Pancreat Dis Int; 2011 Apr; 10(2):179-84. PubMed ID: 21459725
[TBL] [Abstract][Full Text] [Related]
7. Xanthogranulomatous cholecystitis: differentiation from associated gall bladder carcinoma.
Rao RV; Kumar A; Sikora SS; Saxena R; Kapoor VK
Trop Gastroenterol; 2005; 26(1):31-3. PubMed ID: 15974235
[TBL] [Abstract][Full Text] [Related]
8. TP53 abnormalities are frequent and early events in the sequential pathogenesis of gallbladder carcinoma.
Moreno M; Pimentel F; Gazdar AF; Wistuba II; Miquel JF
Ann Hepatol; 2005; 4(3):192-9. PubMed ID: 16177659
[TBL] [Abstract][Full Text] [Related]
9. Vascular endothelial growth factor single-nucleotide polymorphism in gallbladder cancer.
Mishra K; Behari A; Kapoor VK; Khan MS; Prakash S; Agrawal S
J Gastroenterol Hepatol; 2013 Oct; 28(10):1678-85. PubMed ID: 23962084
[TBL] [Abstract][Full Text] [Related]
10. Roles of Salmonella typhi and Salmonella paratyphi in Gallbladder Cancer Development.
Shukla R; Shukla P; Behari A; Khetan D; Chaudhary RK; Tsuchiya Y; Ikoma T; Asai T; Nakamura K; Kapoor VK
Asian Pac J Cancer Prev; 2021 Feb; 22(2):509-516. PubMed ID: 33639667
[TBL] [Abstract][Full Text] [Related]
11. New scoring system for differentiating xanthogranulomatous cholecystitis from gall bladder carcinoma: a tertiary care centre experience.
Rajaguru K; Mehrotra S; Lalwani S; Mangla V; Mehta N; Nundy S
ANZ J Surg; 2018 Jan; 88(1-2):E34-E39. PubMed ID: 27599003
[TBL] [Abstract][Full Text] [Related]
12. [Study on genetic instability of nm23H1 gene in Chinese with original gallbladder tumor].
Lu HY; Zhang GQ; Li JC
Fen Zi Xi Bao Sheng Wu Xue Bao; 2006 Jun; 39(3):249-57. PubMed ID: 16944600
[TBL] [Abstract][Full Text] [Related]
13. [Association of genomic instability of CDH1 gene with clinicopathological characteristics of gastric cancer].
Du J; Wan X; Zhang H; Cao J; Zhao W; Li Z
Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2022 Nov; 39(11):1279-1282. PubMed ID: 36317219
[TBL] [Abstract][Full Text] [Related]
14. E-cadherin and beta-catenin expression in normal, inflamed and cancerous gallbladder tissue.
Puhalla H; Herberger B; Soleiman A; Filipits M; Laengle F; Gruenberger T; Wrba F
Anticancer Res; 2005; 25(6B):4249-54. PubMed ID: 16309224
[TBL] [Abstract][Full Text] [Related]
15. Sequential occurrence of preneoplastic lesions and accumulation of loss of heterozygosity in patients with gallbladder stones suggest causal association with gallbladder cancer.
Jain K; Mohapatra T; Das P; Misra MC; Gupta SD; Ghosh M; Kabra M; Bansal VK; Kumar S; Sreenivas V; Garg PK
Ann Surg; 2014 Dec; 260(6):1073-80. PubMed ID: 24827397
[TBL] [Abstract][Full Text] [Related]
16. Aberrant promoter hypermethylation of multiple genes in gallbladder carcinoma and chronic cholecystitis.
Takahashi T; Shivapurkar N; Riquelme E; Shigematsu H; Reddy J; Suzuki M; Miyajima K; Zhou X; Bekele BN; Gazdar AF; Wistuba II
Clin Cancer Res; 2004 Sep; 10(18 Pt 1):6126-33. PubMed ID: 15447999
[TBL] [Abstract][Full Text] [Related]
17. Genetic alterations in gallbladder adenoma, dysplasia and carcinoma.
Kim YT; Kim J; Jang YH; Lee WJ; Ryu JK; Park YK; Kim SW; Kim WH; Yoon YB; Kim CY
Cancer Lett; 2001 Aug; 169(1):59-68. PubMed ID: 11410326
[TBL] [Abstract][Full Text] [Related]
18. Genome-wide allelotyping analysis reveals multiple sites of allelic loss in gallbladder carcinoma.
Wistuba II; Tang M; Maitra A; Alvarez H; Troncoso P; Pimentel F; Gazdar AF
Cancer Res; 2001 May; 61(9):3795-800. PubMed ID: 11325854
[TBL] [Abstract][Full Text] [Related]
19. Loss of heterozygosity in dysplasia and carcinoma of the gallbladder.
Chang HJ; Kim SW; Kim YT; Kim WH
Mod Pathol; 1999 Aug; 12(8):763-9. PubMed ID: 10463477
[TBL] [Abstract][Full Text] [Related]
20. Usefulness of Ultrasound in Differentiating Xanthogranulomatous Cholecystitis from Gallbladder Carcinoma.
Zhang F; Chen W; Zhang L; Hou C; Zhang M
Ultrasound Med Biol; 2019 Nov; 45(11):2925-2931. PubMed ID: 31447238
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
